Oramed Pharmaceuticals adds new Scientific Advisory Board member.

M2 EQUITYBITES-June 2, 2022-Oramed Pharmaceuticals adds new Scientific Advisory Board member

(C)2022 M2 COMMUNICATIONS http://www.m2.com

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company, announced on Wednesday that it has added Anne Peters, MD to its Scientific Advisory Board.

Dr Peters is a professor of Medicine at the Keck School of Medicine of USC and director of the USC Clinical Diabetes Programs. She earlier directed the clinical diabetes programs at Cedars-Sinai and UCLA. She is the chair of the Endocrine Society Committee on Diabetes Devices and is on the EASD/ADA Technology Safety Committee. She is also a member of the JDRF Panel on Management of Exercise in type 1 Diabetes and a member of the ABIM...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT